Clover Health Investments, Corp
Price
OptionsOpen the Sheet →FilingsNewest: 8-K/A, Director or officer changeSep 24 →InsidersNo open-market buys. 6 insiders sold $2.2M, 13 of 16 sales on a 10b5-1 plan.→HoldersBlackRock $184.0MVanguard $94.5MGeode $56.8M→PeersClosest companies: ALHC, AGL, ASTH→
From the filings
Figures
- Revenue
- $2.48Blast 12 months
- Net income
- −$18.4Mlast 12 months
- Operating cash flow
- $57.3Mlast 12 months
- Cash and equivalents
- $198.8Mat the last balance sheet